Bioagricultivate OÜ

Active Registry code 16618015 OÜ Tallinn Registered 21 Nov 2022
Compare

Bioagricultivate OÜ is a OÜ based in Tallinn, registry code 16618015, status: active. Main activity: Research and experimental development on biotechnology. Its annual report for 2025 shows revenue of €0 and 0 employees.

Revenue
0 €
Employees
0
−1 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2023 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
0204060802023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €20250204060802023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 0 € · +100.0% vs 2024 · industry median 0 € · above 40% of the industry
-400-300-200-10001002023 Company: 16 € Industry median: 0 €20232024 Company: -310 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €2025-400-300-200-10001002023 Company: 16 € Industry median: 0 €20232024 Company: -310 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 0 € · −100.0% vs 2024
051015202023 Company: 16 €20232024 Company: 6 €20242025 Company: 0 €2025051015202023 Company: 16 €20232024 Company: 6 €2025 Company: 0 €2025
Equity, € 2025: 0 € · +100.0% vs 2024
-300-200-10001002023 Company: 16 €20232024 Company: -294 €20242025 Company: 0 €2025-300-200-10001002023 Company: 16 €20232024 Company: -294 €2025 Company: 0 €2025
Employees 2025: 0 · −100.0% vs 2024 · industry median 1 · above 2% of the industry
0.00.20.40.60.81.02023 Company: 0 Industry median: 120232024 Company: 1 Industry median: 120242025 Company: 0 Industry median: 120250.00.20.40.60.81.02023 Company: 0 Industry median: 120232024 Company: 1 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 0 0 0 0 0
2024 0 -310 10 6 -294 1
2023 0 16 0 16 16 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 17 May 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 17 May 2026 Company’s own e-Äriregister
2023 21 Nov 2022 – 31 Dec 2023 30 Jun 2024 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 50215575 / 5
3 Dec 2024
Amendment entry In force
3 Dec 2024
PDF
Ä 50215575 / 4
18 Dec 2023
Amendment entry In force
18 Dec 2023
PDF
Ä 50215575 / 3
21 Nov 2023
Amendment entry In force
21 Nov 2023
PDF
Ä 50215575 / 2
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50215575
21 Nov 2022
First entry In force
21 Nov 2022
PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data